Cargando…

A correlation between gastrointestinal dysfunction and cirrhosis severity

This study aims to investigate the relationship between gastrointestinal dysfunction (GD) and cirrhosis severity in cirrhotic patients, to provide evidences for the prevention and treatment of GD in cirrhotic patients. A total of 95 cirrhotic inpatients and outpatients, who were treated in the Depar...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ping, Zhang, Ying-Jian, Li, Yi-Ran, Liu, Xiao-Min, Lv, Shu-Yan, Xia, Xiao-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156071/
https://www.ncbi.nlm.nih.gov/pubmed/30212936
http://dx.doi.org/10.1097/MD.0000000000012070
_version_ 1783358026783129600
author Wang, Ping
Zhang, Ying-Jian
Li, Yi-Ran
Liu, Xiao-Min
Lv, Shu-Yan
Xia, Xiao-Yan
author_facet Wang, Ping
Zhang, Ying-Jian
Li, Yi-Ran
Liu, Xiao-Min
Lv, Shu-Yan
Xia, Xiao-Yan
author_sort Wang, Ping
collection PubMed
description This study aims to investigate the relationship between gastrointestinal dysfunction (GD) and cirrhosis severity in cirrhotic patients, to provide evidences for the prevention and treatment of GD in cirrhotic patients. A total of 95 cirrhotic inpatients and outpatients, who were treated in the Department of Gastroenterology of Xinqu Hospital of the First Affiliated Hospital of Henan University of Science and Technology, were enrolled in the present study, and assigned as the experimental group (cirrhosis group). According to Child–Pugh classification, these patients were divided into 3 groups: group A (n = 45), group B (n = 23), and group C (n = 27). Forty healthy adults who received health check-ups during the same period served as the control group. The gastrointestinal (GI) symptoms of cirrhotic patients were scored, and the fasting serum gastrin (GAS), motilin (MTL), and vasoactive intestinal peptide (VIP) levels were measured in all subjects. The potential correlations of GI symptom scores of patients in these cirrhosis groups with GI hormone levels and cirrhosis severity were analyzed. In cirrhotic patients, the GI symptom scores significantly increased. Furthermore, the symptom scores gradually increased along with the aggravation of liver damage. Moreover, serum GAS and VIP levels were significantly higher in the cirrhosis groups than in the control group, whereas MTL levels were significantly lower. These changes were significantly correlated with cirrhosis severity. The linear correlation analysis revealed that the GI symptom score was positively correlated with GAS and VIP levels, and negatively correlated with MTL level. In addition, the linear correlation analysis revealed that GI symptom score and GAS and VIP levels were positively correlated with cirrhosis severity, whereas MTL level was negatively correlated with cirrhosis severity. Cirrhotic patients have more obvious GI symptoms and higher GI hormone levels, which are closely correlated with the progression of liver cirrhosis and the degree of liver function damage.
format Online
Article
Text
id pubmed-6156071
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-61560712018-11-08 A correlation between gastrointestinal dysfunction and cirrhosis severity Wang, Ping Zhang, Ying-Jian Li, Yi-Ran Liu, Xiao-Min Lv, Shu-Yan Xia, Xiao-Yan Medicine (Baltimore) Research Article This study aims to investigate the relationship between gastrointestinal dysfunction (GD) and cirrhosis severity in cirrhotic patients, to provide evidences for the prevention and treatment of GD in cirrhotic patients. A total of 95 cirrhotic inpatients and outpatients, who were treated in the Department of Gastroenterology of Xinqu Hospital of the First Affiliated Hospital of Henan University of Science and Technology, were enrolled in the present study, and assigned as the experimental group (cirrhosis group). According to Child–Pugh classification, these patients were divided into 3 groups: group A (n = 45), group B (n = 23), and group C (n = 27). Forty healthy adults who received health check-ups during the same period served as the control group. The gastrointestinal (GI) symptoms of cirrhotic patients were scored, and the fasting serum gastrin (GAS), motilin (MTL), and vasoactive intestinal peptide (VIP) levels were measured in all subjects. The potential correlations of GI symptom scores of patients in these cirrhosis groups with GI hormone levels and cirrhosis severity were analyzed. In cirrhotic patients, the GI symptom scores significantly increased. Furthermore, the symptom scores gradually increased along with the aggravation of liver damage. Moreover, serum GAS and VIP levels were significantly higher in the cirrhosis groups than in the control group, whereas MTL levels were significantly lower. These changes were significantly correlated with cirrhosis severity. The linear correlation analysis revealed that the GI symptom score was positively correlated with GAS and VIP levels, and negatively correlated with MTL level. In addition, the linear correlation analysis revealed that GI symptom score and GAS and VIP levels were positively correlated with cirrhosis severity, whereas MTL level was negatively correlated with cirrhosis severity. Cirrhotic patients have more obvious GI symptoms and higher GI hormone levels, which are closely correlated with the progression of liver cirrhosis and the degree of liver function damage. Wolters Kluwer Health 2018-09-14 /pmc/articles/PMC6156071/ /pubmed/30212936 http://dx.doi.org/10.1097/MD.0000000000012070 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Research Article
Wang, Ping
Zhang, Ying-Jian
Li, Yi-Ran
Liu, Xiao-Min
Lv, Shu-Yan
Xia, Xiao-Yan
A correlation between gastrointestinal dysfunction and cirrhosis severity
title A correlation between gastrointestinal dysfunction and cirrhosis severity
title_full A correlation between gastrointestinal dysfunction and cirrhosis severity
title_fullStr A correlation between gastrointestinal dysfunction and cirrhosis severity
title_full_unstemmed A correlation between gastrointestinal dysfunction and cirrhosis severity
title_short A correlation between gastrointestinal dysfunction and cirrhosis severity
title_sort correlation between gastrointestinal dysfunction and cirrhosis severity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156071/
https://www.ncbi.nlm.nih.gov/pubmed/30212936
http://dx.doi.org/10.1097/MD.0000000000012070
work_keys_str_mv AT wangping acorrelationbetweengastrointestinaldysfunctionandcirrhosisseverity
AT zhangyingjian acorrelationbetweengastrointestinaldysfunctionandcirrhosisseverity
AT liyiran acorrelationbetweengastrointestinaldysfunctionandcirrhosisseverity
AT liuxiaomin acorrelationbetweengastrointestinaldysfunctionandcirrhosisseverity
AT lvshuyan acorrelationbetweengastrointestinaldysfunctionandcirrhosisseverity
AT xiaxiaoyan acorrelationbetweengastrointestinaldysfunctionandcirrhosisseverity
AT wangping correlationbetweengastrointestinaldysfunctionandcirrhosisseverity
AT zhangyingjian correlationbetweengastrointestinaldysfunctionandcirrhosisseverity
AT liyiran correlationbetweengastrointestinaldysfunctionandcirrhosisseverity
AT liuxiaomin correlationbetweengastrointestinaldysfunctionandcirrhosisseverity
AT lvshuyan correlationbetweengastrointestinaldysfunctionandcirrhosisseverity
AT xiaxiaoyan correlationbetweengastrointestinaldysfunctionandcirrhosisseverity